
51 - 200 employees
Founded 2016
💰 $205M Post-IPO Equity on 2022-06
Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Our most advanced investigational product candidate, apitegromab (SRK-015), a
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 August 4
51 - 200
Director leading US and global congresses, medical meetings, and internal events for Scholar Rock, a biopharmaceutical company developing apitegromab for SMA. Managing budgets, vendors, compliance, logistics, and post-event optimization across complex healthcare programs.
🍂 Massachusetts – Remote
💵 $200k - $250k / year
💰 $205M Post-IPO Equity on 2022-06
⏰ Full Time
🔴 Lead
🎪 Events
👻 Ghost score 1%
🕒 July 28
51 - 200
Regional leader for Rx Onboarding and Care Coordinator team, improving patient onboarding and treatment support for SMA. Collaborates with cross-functional teams ensuring patient experience excellence.
🗣️🇪🇸 Spanish Required
🕒 July 28
51 - 200
Associate Director/Director of Patient Marketing for apitegromab at a biopharmaceutical company. Focus on developing patient engagement strategies and executing promotional tactics.
🍂 Massachusetts – Remote
💰 $205M Post-IPO Equity on 2022-06
⏰ Full Time
🟠 Senior
🎡 Marketing
👻 Ghost score 11%
🕒 June 24
51 - 200
Sr. Medical Science Liaison developing relationships with KOLs and delivering scientific presentations. Supporting clinical development for SMA treatments in a remote environment.
🇺🇸 United States – Remote
💵 $220k - $250k / year
💰 $205M Post-IPO Equity on 2022-06
⏰ Full Time
🟠 Senior
👻 Ghost score 2%